LENZ

LENZ Therapeutics, Inc. - Common Stock (LENZ)

About LENZ Therapeutics, Inc. - Common Stock (LENZ)

LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Solana Beach, CA.

Details

Daily high

$24.58

Daily low

$23.01

Price at open

$23.03

52 Week High

$38.93

52 Week Low

$14.42

Market cap

635.1M

Dividend yield

0.00%

Volume

218,755

Avg. volume

307,773

P/E ratio

-4.84

LENZ Therapeutics, Inc. - Common Stock News